Clinical risk factor for neuroleptic malignant syndrome

Human Psychopharmacology

Volumn 17, Issue 2, 2002, Pages 99-102

  Berardi, Domenico ^a,c   Dell'Atti, Maddalena ^a   Amore, Mario ^b   De Ronchi, Diana ^a   Ferrari, Giuseppe ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c Institute of Psychiatry   (Italy)

Author keywords

Catatonia; Disorganization; Neuroleptic malignant syndrome; Psychomotor agitation; Risk factors

Indexed keywords

BENZODIAZEPINE; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; LITHIUM; NEUROLEPTIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

ADULT; AGED; ARTICLE; BEHAVIOR DISORDER; BIOEQUIVALENCE; CATATONIA; CLINICAL ARTICLE; CONFUSION; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DISORIENTATION; DRUG RESPONSE; FEMALE; HUMAN; MALE; MANIC DEPRESSIVE PSYCHOSIS; MENTAL DEFICIENCY; MENTAL DISEASE; NEUROLEPTIC MALIGNANT SYNDROME; PATIENT CODING; PRIORITY JOURNAL; PSYCHOSIS; RESTLESSNESS; RISK FACTOR; SCHIZOPHRENIA; HEBEPHRENIA; INFORMATION PROCESSING; MIDDLE AGED; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; SYNDROME;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; CATATONIA; DATA COLLECTION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROLEPTIC MALIGNANT SYNDROME; PSYCHOMOTOR AGITATION; RISK FACTORS; SCHIZOPHRENIA, DISORGANIZED; SCHIZOPHRENIC PSYCHOLOGY; SYNDROME;

EID: 0035990672     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.376     Document Type: Article

References (26)

1. Atypical neuroleptic malignant syndrome associated with clozapine treatment
2. Clinical and pharmacological risk factors for neuroleptic malignant syndrome: A case-control study
3. Catatonia and the neuroleptics: Psychobiologic significance of remote and recent findings
4. Catatonia. II. Treatment with lorazepam and electroconvulsive therapy
5. Neuroleptic malignant syndrome
6. Dose equivalence of the antipsychotic drugs
7. Neuroleptic catatonia and its relationship to psychogenic catatonia
8. The catatonic syndrome
9. Novel antipsychotics and the neuroleptic malignant syndrome: A review and critique
10. Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients
11. Catatonia: The tension insanity
12. Risk factors for neuroleptic malignant syndrome
13. Lethal catatonia
14. Lethal catatonia and neuroleptic malignant syndrome. A dopamine receptor shut-down hypothesis
15. Synergism of lorazepam and electroconvulsive therapy in the treatment of catatonia
16. Frequency and presentation of neuroleptic malignant syndrome in large psychiatric hospital
17. Motor Disorders in Psychiatry: Towards A Neurological Psychiatry
18. Late-onset Tay-Sachs disease presenting as catatonic schizophrenia: Diagnostic and treatment issues
19. Case-control study of neuroleptic malignant syndrome
20. Catatonia, a review of a behavioral neurologic syndrome
21. Catatonia and the NMS-a single entity?
22. Catatonia: Harbinger of the neuroleptic malignant syndrome